Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Papers
(The median citation count of Pregnancy Hypertension-An International Journal of Womens Cardiovascul is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice306
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia80
Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota52
Adverse pregnancy outcomes among mothers with hypertensive disorders in pregnancy: A meta-analysis of cohort studies37
Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis34
Effects of statins on preeclampsia: A systematic review28
Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review26
Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children’s study22
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study21
Hypertension in pregnancy: Prevalence, risk factors and outcomes for women birthing in Ireland17
Neuropathophysiology of preeclampsia and eclampsia: A review of cerebral hemodynamic principles in hypertensive disorders of pregnancy17
Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial16
Resveratrol and grape juice: Effects on redox status and nitric oxide production of endothelial cells in in vitro preeclampsia model16
Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: Results from a national multicenter study on COVID in Brazil, the REBRACO initiative15
Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study15
The role of tumor necrosis factor in triggering activation of natural killer cell, multi-organ mitochondrial dysfunction and hypertension during pregnancy15
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway14
How digital health affects the patient-physician relationship: An empirical-ethics study into the perspectives and experiences in obstetric care14
Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study14
Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease14
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms14
SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia12
Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium12
Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats12
Who said differentiating preeclampsia from COVID-19 infection was easy?12
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-1912
Changes to management of hypertension in pregnancy, and attitudes to self-management: An online survey of obstetricians, before and following the first wave of the COVID-19 pandemic11
Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction11
Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis11
Preconception dietary inflammatory index and hypertension disorders of pregnancy: The Japan environment and children's study11
Screening for primary aldosteronism in pregnancy11
Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio11
Maternal diseases and risk of hypertensive disorders of pregnancy across gestational age groups10
Flavonoids exert potential in the management of hypertensive disorders in pregnancy10
Gestational weight gain and adverse pregnancy outcomes by pre-pregnancy BMI category in women with chronic hypertension: A cohort study10
Association of Aquaporin-3, Aquaporin-7, NOS3 and CYBA polymorphisms with hypertensive disorders in women10
Protein-creatinine ratio and albumin-creatinine ratio for the diagnosis of significant proteinuria in pregnant women with hypertension: Systematic review and meta-analysis of diagnostic test accuracy10
Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules10
Blood pressure changes in gestational hypertension, preeclampsia, and chronic hypertension from preconception to 42-day postpartum10
Mitochondrial DNA copy number variation – A potential biomarker for early onset preeclampsia9
Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia9
Identification of potential crucial genes associated with early-onset preeclampsia via bioinformatic analysis9
Adherence with blood pressure self-monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP9
Adherence to anti-hypertensive medication in pregnancy9
Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats9
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence9
Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe8
Validation of the fullPIERS model for prediction of adverse outcomes in preeclampsia at a referral center8
Hypertensive disorders in pregnancy – Trends over eight years: A population-based cohort study8
Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010–20198
Pregnancy outcomes in women with hyponatraemia and preeclampsia: Case series and literature review8
Maternal and neonatal complications in women with medical comorbidities and preeclampsia8
Histopathological features of kidney and renal prognosis in patients with preeclampsia8
Alterations in maternal sFlt-1 and PlGF: Time to labor onset in term-/late-term pregnancies with and without placental dysfunction7
Self-monitoring of blood pressure in pregnancy: A mixed methods evaluation of a national roll-out in the context of a pandemic7
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy7
Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia7
The non-traditional and familial risk factors for preeclampsia in the FINNPEC cohort7
Preeclampsia and low sodium: A retrospective cohort analysis and literature review7
Predictors of posterior reversible encephalopathy syndrome in women with hypertension in pregnancy: A prospective observational study7
Hypertension in pregnancy as a possible factor for child autistic behavior at two years old7
Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States7
Diagnosis of placental insufficiency independently of clinical presentations using sFlt-1/PLGF ratio, including SGA patients7
Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management7
Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy7
The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: A randomized placebo-controlled study7
Low-dose aspirin increases 15-epi-lipoxins A4 in pregnancies at high-risk for developing preeclampsia7
Congo red dot test in the early prediction and diagnosis of pre-eclampsia in a tertiary health care centre in India7
What is the role of glycemic control in the development of preeclampsia among women with type 1 diabetes?7
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis7
Pre-eclampsia is associated with complement pathway activation in the maternal and fetal circulation, and placental tissue7
Stage 1 hypertension defined by the 2017 ACC/AHA guidelines and neonatal outcomes: Systematic review and meta-analysis7
Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysis7
Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?7
Uncaria tomentosa extract (AC-11) improves pregnancy hypertension together with suppression of sFlt-1 and sEng6
Angiogenic factors and prediction for ischemic placental disease in future pregnancies6
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women6
Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio6
Clinical factors associated with preeclampsia recurrence6
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia – A qualitative study6
Risk of unplanned healthcare utilization in postpartum period for patients with hypertensive disorders of pregnancy6
Association of glutamate cystein ligase (GCL) activity Peroxiredoxin 4 (prxR4) and apelin levels in women with preeclampsia6
Metabolic syndrome following hypertensive disorders in pregnancy in a low-resource setting: A cohort study6
High blood pressure at entry into antenatal care and birth outcomes among a cohort of HIV-uninfected women and women living with HIV initiating antiretroviral therapy in South Africa6
Preeclampsia and the crucial postpartum period for Covid-19 infected mothers: A case report6
Role of sFLT-1/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women6
Good performance of bioimpedance in early pregnancy to predict preeclampsia6
Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective6
Small extracellular vesicles from plasma of women with preeclampsia increase myogenic tone and decrease endothelium-dependent relaxation of mouse mesenteric arteries6
Acute pulmonary edema due to severe preeclampsia in advanced maternal age women6
Preeclampsia and high blood pressure in early pregnancy as risk factors of severe maternal cardiovascular disease during 50-years of follow-up6
Correlation between corin, N-terminal pro-atrial natriuretic peptide and neonatal adverse prognostic in hypertensive disorders of pregnancy5
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia5
Longitudinal changes in angiogenesis biomarkers within 72 h of diagnosis and time-to-delivery in early-onset preeclampsia5
Maternal low birth weight and hypertensive disorders of pregnancy5
Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes5
Increased urinary albumin leakage is related to injuries of glomerular glycocalyx and podocytes, and associated with tubular dysfunction in preeclampsia5
A point-of care urine test to predict preeclampsia development in Asian women with suspected preeclampsia5
Lower blood pressure achieved leads to better pregnant outcomes in non-severe chronic hypertensive pregnant women5
Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study5
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study5
Do modifiable risk factors for cardiovascular disease post-pregnancy influence the association between hypertensive disorders of pregnancy and cardiovascular health outcomes? A systematic review of ob5
Long intergenic ncRNA 00473 improves the invasion of trophoblastic cells via miR-16-5p5
Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia5
Subclinical cardiac performance in obese and overweight women as a potential risk factor of preeclampsia5
Determining psychological distress during pregnancy and its association with the development of a hypertensive disorder5
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway4
RUPP Th17s cause hypertension and mitochondrial dysfunction in the kidney and placenta during pregnancy4
Development and external validation of a model for predicting adverse outcomes in women with preeclampsia: A retrospective study from two trans-regional centers in China4
Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy4
Pregnancy in patients with stage 3–5 CKD: Maternal and fetal outcomes4
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia4
The ability and safety of community-based health workers to safely initiate lifesaving therapies for pre-eclampsia in Ogun State, Nigeria: An analysis of 260 community treatments with MgSO4 and/or met4
Platelet counts during normal pregnancies and pregnancies complicated with hypertensive disorders4
Association between aspirin use during pregnancy and cardiovascular risk factors 2–7 years after delivery: The nuMoM2b Heart Health Study4
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study4
Association between brain natriuretic peptide and cardiac dysfunction in hypertensive pregnancy disorders4
Glycyrrhizin potentially suppresses the inflammatory response in preeclampsia rat model4
Multimodal fusion model for classifying placenta ultrasound imaging in pregnancies with hypertension disorders4
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial4
Incidence of essential hypertension but not echocardiographic abnormalities at four years with a history of preeclampsia with severe features4
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia4
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial4
Eclampsia in Italy: A prospective population-based study (2017–2020)4
Maternal macro- and micronutrient intake six months after hypertensive versus normotensive pregnancy: is poor diet quality contributing to future cardiometabolic disease risk?4
Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?4
Change in prevalence of chronic hypertension in pregnancy after the updated ACC/AHA hypertension guidelines4
Reduction of serum-induced endothelial STAT3(Y705) activation is associated with preeclampsia4
Hypertension and infant outcomes: North Carolina pregnancy risks assessment monitoring system data3
Perinatal outcomes and 2017 ACC/AHA blood pressure categories3
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time3
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia3
Decreased expression of caveolin-1 have relevance to promoted senescence in preeclamptic placenta3
Epicardial adipose tissue thickness as a potential predictor of pre-eclampsia3
First trimester fetal thymus volume may predict preeclampsia3
Maternal near-miss attributable to haemorrhagic stroke in patients with hypertensive disorders of pregnancy in Japan: A national cohort study3
Predictive value of the complement factors B and H for women with gestational diabetes mellitus who are at risk of preeclampsia3
Eclampsia with RCVS: Postpartum seizure provoked by methergine3
Elevated serum progesterone during in vitro fertilization treatment and the risk of ischemic placental disease3
Hypertension at delivery hospitalization – United States, 2016–20173
Effect of positioning on blood pressure measurement in pregnancy3
Medical expenditures for hypertensive disorders during pregnancy that resulted in a live birth among privately insured women3
The protective effect of magnesium sulfate on placental inflammation via suppressing the NF-κB pathway in a preeclampsia-like rat model3
Novel associations of SNPs MYLIP rs3757354 and ABCA1 2230806 gene with early-onset-preeclampsia: A case-control candidate genetic study3
Preconception ovarian reserve and placenta-mediated pregnancy complications among infertile women3
Maternal birth weight as an indicator of early-onset and late-onset hypertensive disorders of pregnancy: The Japan Environment and Children’s study3
Clinical presentation and predictors of eclampsia among women with hypertensive disorders of pregnancy in Ghana3
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy3
Characteristics of preeclampsia in donor cell gestations3
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia3
Healthy and preeclamptic pregnancies show differences in Guanylate-Binding Protein-1 plasma levels3
Optimising timing of steroid administration in preterm pre-eclampsia3
Correlation between cognitive assessment scores and circulating cerebral biomarkers in women with pre-eclampsia and eclampsia3
Implementation of a novel shared decision-making intervention in women with chronic hypertension in pregnancy: multiple-site multiple-method investigation3
Evaluation of Klotho gene expression and NGAL levels following acute kidney injury during pregnancy hypertensive disorders3
Factors associated with poor fetal outcome in placental abruption3
Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction3
Pregnancy restores altered sympathetic vasomotor modulation and parasympathetic cardiac modulation in hypertensive rats3
Postpartum ambulatory and home blood pressure monitoring in women with history of preeclampsia: Diagnostic agreement and detection of masked hypertension3
The association between maternal tea consumption and the risk of pregnancy induced hypertension: A retrospective cohort study in Lanzhou, China3
External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study3
Clinical implementation of pre-eclampsia screening in the first trimester of pregnancy3
Hypertensive disorders of pregnancy and occurrence of ADHD, ASD, and epilepsy in the child: A meta-analysis2
First trimester serum matrix metalloproteinase-7 is a poor predictor of late-onset preeclampsia2
A wide range of triglyceride levels is sufficient for fetal growth at gestational weeks 12–16, but higher triglyceride levels are associated with gestational hypertension2
Evaluation of a protein-to-creatinine dipstick diagnostic test for proteinuria screening in selected antenatal care clinics in three Districts in the Bono-East Region of Ghana2
Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?2
Postnatal cardiovascular morbidity following preterm pre-eclampsia: An observational study2
Effects of maternal hypertension on cord blood Arginine vasopressin receptor expression2
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women2
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia2
Interleukin-17 induces hypertension but does not impair cerebrovascular function in pregnant rats2
A new look at the role of nitric oxide in preeclampsia: Protein S-nitrosylation2
Improving obstetric and perinatal outcomes with a remote patient monitoring program for hypertension in a large integrated care system2
Treatment of acute-onset hypertension in pregnancy: A network meta-analysis of randomized controlled trials comparing anti-hypertensives and route of administration2
Dynamic cerebral autoregulation in postpartum individuals with and without preeclampsia2
A retrospective cohort study of hypertension, cardiovascular disease, and metabolic syndrome risk in women with history of preterm and term preeclampsia five years after delivery2
Reduced urinary angiotensinogen excretion in preeclampsia2
Association between human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes: A systematic review and meta-analysis2
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states2
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-contr2
Soluble concentrations of the terminal complement complex C5b-9 correlate with end-organ injury in preeclampsia2
Low indoleamine 2, 3 dioxygenase (IDO) activity is associated with psycho-obstetric risk2
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome2
The P4 study: Subsequent pregnancy maternal physiology after hypertensive and normotensive pregnancies2
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast2
Pregnancy and severely reduced renal mass: A stress model showing renal hyperfiltration2
Magnesium sulfate in preeclampsia: Broad indications, not only in neurological symptoms2
Longitudinal changes of angiogenic factors as a potential predictive tool in women with suspected preeclampsia2
Upregulation of exofacial peroxiredoxin-thioredoxin system of lymphocytes and monocytes in preeclampsia2
Current state of affairs: A study regarding diagnosis, treatment and use of home blood pressure monitoring for hypertension in pregnancy2
Persistence of abnormal uterine artery flow postpartum: Case-control study2
Influence of drug-related problems on length of hospital stay of women with a history of preeclampsia: A multicenter study2
Risk factors for needing postpartum antihypertensive medications with hypertensive disorders: Timing of diagnosis, presence of proteinuria, and severity of disease2
The plasma antioxidant vitamin status of the INTAPP cohort examined: The unsuspected importance of β-carotene and γ-tocopherol in preeclampsia2
Maternal bradycardia heralding deteriorating HELLP syndrome (pregnancy hypertension)2
Dietary protein source contributes to the risk of developing maternal syndrome in the Dahl salt-sensitive rat2
The effect of comorbidities on the sFLT-1:PlGF ratio in preeclampsia2
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models2
Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women2
Maternal one carbon metabolism and interleukin-10 &-17 synergistically influence the mode of delivery in women with Early Onset Pre-Eclampsia1
P-017. The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: Economic evaluation1
Hypertensive pregnancy complications and maternal characteristics as predictors of cardiovascular health within ten years after delivery1
Sleep disordered breathing and the risk of severe maternal morbidity in women with preeclampsia: A population-based study1
The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin1
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes1
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials1
The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center1
Appraisal of hepatocyte growth factor signal transduction in the duality of HIV associated pre-eclampsia1
Persistence of abnormal uterine artery flow postpartum: A letter1
P-048. Stringent laboratory monitoring of pre-eclampsia and gestational hypertension: Improving care in low-resource settings1
P-101. Pregnancy and infant outcomes for golimumab therapy for ulcerative colitis during the pregnancy and lactation periods: a retrospective report1
First-trimester prediction model for placental vascular disorders: An observational prospective study1
Determinants of eclampsia in women with severe preeclampsia at Mpilo Central Hospital, Bulawayo, Zimbabwe1
Plasma angiotensin II levels in women with severe preeclampsia under magnesium sulfate regimen1
Prediction of adverse outcome by ophthalmic artery Doppler and angiogenic markers in pregnancies with new onset hypertension1
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy1
Intra-arterial versus oscillometric blood pressure measurements in women with severe peripartum hypertension undergoing urgent treatment with nicardipine: An observational study1
Hypertensive disorders of pregnancy among women with a history of leukemia or lymphoma1
Continuous non-invasive hemodynamic monitoring in early onset severe preeclampsia1
Rural-urban residence and sequelae of hypertensive disorders of pregnancy in the first year postpartum, 2007 – 20191
Persistent postpartum hypertension 3 months post-delivery among women with hypertensive disorders of pregnancy in Tanzania: A multicenter cohort study1
Amount of proteinuria as associated with severity classification of pregnant women with preeclampsia1
Increased oxidative stress and endothelial activation in umbilical veins from pregnancies diagnosed with preeclampsia1
The role of Tenascin-C in HIV associated pre-eclampsia1
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies1
Pregnancy hypertension: An international journal of women's cardiovascular health – Reply: Letter to the editor1
Prediction of adverse neonatal outcome at admission for early-onset preeclampsia with severe features1
Factors influencing perinatal outcomes in women with preterm preeclampsia: A secondary analysis of the PHOENIX trial1
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?1
Health care workers and key policy informant’s knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women1
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta1
Clinical features of preeclampsia and hypertensive disorders in pregnancies after different frozen embryo transfer regimens1
Effect of tenofovir alafenamide in combination with and without integrase inhibitors on weight gain, diabetes, and hypertensive disorders of pregnancy1
Choosing cesarean section over natural birth: Challenges of decision making among pregnant women with pre-eclampsia in Ado-Ekiti1
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study1
Evaluation of the association of the Renalase rs10887800 polymorphism with the risk of preeclampsia in Brazilian women1
Why does pre-eclampsia exist?: An evolutionary theory1
Pregnancy outcomes of women presenting with stage 1 hypertension during the first prenatal clinic visit before 20 gestational weeks1
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia1
Validation of the French translation of a self-administered questionnaire looking for a history of pre-eclampsia1
P-009. Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia1
miR-204-5p promotes preeclampsia serum-induced injury in human umbilical vein endothelial cells through regulation of the PTPRJ/Notch axis1
P-099. Previous preeclampsia and its association with future cardiovascular diseases: A systematic review and meta-analysis1
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta1
Impact of hypertensive disorders of pregnancy on respiratory outcomes in extremely and very preterm infants: A population-based study in Japan1
Withstanding the test of time: Morning versus afternoon/evening urine protein-to-creatinine ratios in preeclampsia1
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery1
Cerebral hemodynamics and vasoconstriction in preeclampsia: From diagnosis to resolution1
Maternal haemodynamic profile in pregnancy after assisted reproductive technology: A pilot study1
0.053961992263794